FOLATE AND MTHFR POLYMORPHISMS IN SLEEP, ANXIETY, AND DEPRESSION, AND VITAMIN B12 IN ANXIETY AND DEPRESSION: A REVIEW OF CURRENT EVIDENCE
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5541Keywords:
Folate, MTHFR, Sleep, Anxiety, Depression, Vitamin B12Abstract
One-carbon metabolism supports neuropsychiatric function by providing the substrates needed for monoamine neurotransmitter synthesis. In this review, we summarize the available evidence on selected B vitamins and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms in relation to sleep outcomes, depression, and anxiety in adults. A PubMed search was conducted, through which 27 studies relevant to the review were identified. Observational studies suggest that the relationship between serum folate and sleep is complex, with findings remaining inconsistent across the literature. Nevertheless, improvements in sleep disturbance outcomes following L-methylfolate supplementation among individuals with MTHFR C677T/A1298C polymorphisms provide preliminary support for a link between vitamin B9 metabolism and sleep regulation. In the context of depression and anxiety, observational studies also yielded mixed results. However, interventional studies suggest that supplementation with L-methylfolate at doses exceeding 7.5 mg/day may enhance the response to antidepressant treatment in patients with depression. Furthermore, among patients with major depressive disorder and low-normal vitamin B12 levels, adjunctive therapy with weekly intramuscular injections of 1,000 µg vitamin B12 may improve treatment response. Evidence regarding the role of MTHFR polymorphisms in anxiety and depression remains inconclusive, although some studies suggest that reduced MTHFR activity may be associated with an increased risk of these conditions and that supplementation with a reduced B vitamins and micronutrient complex may offer clinical benefit. In conclusion, vitamin B status and MTHFR polymorphisms may be related to both sleep and anxiety/depressive symptoms. However, because the current evidence remains inconsistent, further large-scale longitudinal studies and well-designed randomized controlled trials are needed.
References
Almeida, O. P., Ford, A. H., Hirani, V., Singh, V., van Bockxmeer, F. M., McCaul, K., & Flicker, L. (2014). B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: Results from the B-VITAGE randomised, double-blind, placebo-controlled trial. The British Journal of Psychiatry, 205(6), 450–457. https://doi.org/10.1192/bjp.bp.114.145177
Alpert, M., Silva, R. R., & Pouget, E. R. (2003). Prediction of treatment response in geriatric depression from baseline folate level: Interaction with an SSRI or a tricyclic antidepressant. Journal of Clinical Psychopharmacology, 23(3), 309–313. https://doi.org/10.1097/01.jcp.0000084024.22282.cd
An, H., Xue, Q., & Zhang, J. (2023). The association between serum total folic acid concentration and severe difficulty falling asleep in US adults: NHANES 2005–2008. Frontiers in Neurology, 14, Article 1225403. https://doi.org/10.3389/fneur.2023.1225403
Araszkiewicz, A. F., Jańczak, K., Wójcik, P., Białecki, B., Kubiak, S., Szczechowski, M., & Januszkiewicz-Lewandowska, D. (2025). MTHFR gene polymorphisms: A single gene with wide-ranging clinical implications—A review. Genes, 16(4), Article 441. https://doi.org/10.3390/genes16040441
Bedson, E., Bell, D., Carr, D., Carter, B., Hughes, D., Jorgensen, A., Lewis, H., Lloyd, K., McCaddon, A., Moat, S., Pink, J., Pirmohamed, M., Roberts, S., Russell, I., Sylvestre, Y., Tranter, R., Whitaker, R., Wilkinson, C., & Williams, N. (2014). Folate augmentation of treatment—Evaluation for depression (FolATED): Randomised trial and economic evaluation. Health Technology Assessment, 18(48), vii–159. https://doi.org/10.3310/hta18480
Beydoun, M. A., Gamaldo, A. A., Canas, J. A., Beydoun, H. A., Shah, M. T., McNeely, J. M., & Zonderman, A. B. (2014). Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys. PLOS ONE, 9(8), Article e103490. https://doi.org/10.1371/journal.pone.0103490
Bjelland, I., Tell, G. S., Vollset, S. E., Refsum, H., & Ueland, P. M. (2003). Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Archives of General Psychiatry, 60(6), 618–626. https://doi.org/10.1001/archpsyc.60.6.618
Botto, L. D., & Yang, Q. (2000). 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. American Journal of Epidemiology, 151(9), 862–877. https://doi.org/10.1093/oxfordjournals.aje.a010290
Bottiglieri, T. (2002). S-adenosyl-L-methionine (SAMe): From the bench to the bedside—Molecular basis of a pleiotrophic molecule. The American Journal of Clinical Nutrition, 76(5), 1151S–1157S. https://doi.org/10.1093/ajcn/76/5.1151S
Carboni, L., Delafont, B., Ivanchenko, E., Ratti, E., Learned, S. M., Alexander, R., & Domenici, E. (2021). Folate metabolism biomarkers from two randomised placebo-controlled clinical studies with paroxetine and venlafaxine. The World Journal of Biological Psychiatry, 22(4), 315–321. https://doi.org/10.1080/15622975.2020.1805509
Carmon, A. S., Amato, R. J., Patel, S. M., & Finks, S. W. (2024). Effect of L-methylfolate supplementation on sleep for patients with reduced methylenetetrahydrofolate reductase activity. Journal of Dietary Supplements, 21(5), 576–584. https://doi.org/10.1080/19390211.2024.2327541
Cavalcante-Silva, V., da Silva Vallim, J. R., de Oliveira, A. C., D’Almeida, V., Tufik, S., & Andersen, M. L. (2025). The relationship between cobalamin and folate below the cutoff values on anxiety and insomnia symptoms: Findings from the 8-year longitudinal EPISONO study. Journal of Affective Disorders, 391, Article 119968. https://doi.org/10.1016/j.jad.2025.119968
Cheng, C., Chen, X., Zhang, L., Wang, Z., Duan, H., Wu, Q., Yan, R., Wang, D., Li, Z., He, R., Li, Z., Chen, Y., Ma, F., Du, Y., Li, W., & Huang, G. (2024). A risk correlative model for sleep disorders in Chinese older adults based on blood micronutrient levels: A matched case-control study. Nutrients, 16(19), Article 3306. https://doi.org/10.3390/nu16193306
Coppen, A., & Bailey, J. (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. Journal of Affective Disorders, 60(2), 121–130. https://doi.org/10.1016/s0165-0327(00)00153-1
Dong, Y., & Luo, M. (2024). Association between serum folate and sleep duration in American adults: A cross-sectional analysis of the National Health and Nutrition Examination Survey 2005 to 2010. Medicine, 103(48), Article e40767. https://doi.org/10.1097/MD.0000000000040767
Eszlari, N., Bruncsics, B., Millinghoffer, A., Hullam, G., Petschner, P., Gonda, X., Breen, G., Antal, P., Bagdy, G., Deakin, J. F. W., & Juhasz, G. (2021). Biology of perseverative negative thinking: The role of timing and folate intake. Nutrients, 13(12), Article 4396. https://doi.org/10.3390/nu13124396
Froese, D. S., Fowler, B., & Baumgartner, M. R. (2019). Vitamin B12, folate, and the methionine remethylation cycle—Biochemistry, pathways, and regulation. Journal of Inherited Metabolic Disease, 42(4), 673–685. https://doi.org/10.1002/jimd.12009
Gao, J., Cahill, C. M., Huang, X., Roffman, J. L., Lamon-Fava, S., Fava, M., Mischoulon, D., & Rogers, J. T. (2018). S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics, 15(1), 156–175. https://doi.org/10.1007/s13311-017-0593-0
He, Q., & Li, J. (2023). The evolution of folate supplementation—From one size for all to personalized, precision, poly-paths. Journal of Translational Internal Medicine, 11(2), 128–137. https://doi.org/10.2478/jtim-2023-0087
Kendrick, T., Dunn, N., Robinson, S., Oestmann, A., Godfrey, K., Cooper, C., Inskip, H., & Southampton Women’s Survey Study Group. (2008). A longitudinal study of blood folate levels and depressive symptoms among young women in the Southampton Women’s Survey. Journal of Epidemiology and Community Health, 62(11), 966–972. https://doi.org/10.1136/jech.2007.069765
Leclerc, D., & Rozen, R. (2007). Génétique moléculaire de MTHFR: Les polymorphismes ne sont pas tous bénins [Molecular genetics of MTHFR: Polymorphisms are not all benign]. Médecine/Sciences, 23(3), 297–302. https://doi.org/10.1051/medsci/2007233297
Lok, A., Mocking, R. J., Assies, J., Koeter, M. W., Bockting, C. L., de Vries, G. J., Visser, I., Derks, E. M., Kayser, M., & Schene, A. H. (2014). The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder: Influence of antidepressant use and depressive state? Journal of Affective Disorders, 166, 115–123. https://doi.org/10.1016/j.jad.2014.04.048
Mech, A. W., & Farah, A. (2016). Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism: A randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry, 77(5), 668–671. https://doi.org/10.4088/JCP.15m10166
Moore, K., Hughes, C. F., Hoey, L., Ward, M., Cunningham, C., Molloy, A. M., Strain, J. J., McCarroll, K., Casey, M. C., Tracey, F., Laird, E., O’Kane, M., & McNulty, H. (2019). B-vitamins in relation to depression in older adults over 60 years of age: The Trinity Ulster Department of Agriculture (TUDA) cohort study. Journal of the American Medical Directors Association, 20(5), 551–557.e1. https://doi.org/10.1016/j.jamda.2018.11.031
Møllehave, L. T., Skaaby, T., Simonsen, K. S., Thuesen, B. H., Mortensen, E. L., Sandholt, C. H., Pedersen, O., Grarup, N., Hansen, T., & Linneberg, A. (2017). Association studies of genetic scores of serum vitamin B12 and folate levels with symptoms of depression and anxiety in two Danish population studies. European Journal of Clinical Nutrition, 71(9), 1054–1060. https://doi.org/10.1038/ejcn.2017.97
Papakostas, G. I., Petersen, T., Mischoulon, D., Green, C. H., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004). Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: Predictors of relapse during the continuation phase of pharmacotherapy. The Journal of Clinical Psychiatry, 65(8), 1096–1098. https://doi.org/10.4088/jcp.v65n0811
Papakostas, G. I., Petersen, T., Mischoulon, D., Ryan, J. L., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004). Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 1: Predictors of clinical response in fluoxetine-resistant depression. The Journal of Clinical Psychiatry, 65(8), 1090–1095. https://doi.org/10.4088/jcp.v65n0810
Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Bottiglieri, T., Roffman, J., Cassiello, C., Stahl, S. M., & Fava, M. (2014). Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: Results from a randomized clinical trial. The Journal of Clinical Psychiatry, 75(8), 855–863. https://doi.org/10.4088/JCP.13m08947
Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., Pencina, M., Meisner, A., Bottiglieri, T., Nelson, E., Mischoulon, D., Alpert, J. E., Barbee, J. G., Zisook, S., & Fava, M. (2012). L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind, parallel-sequential trials. The American Journal of Psychiatry, 169(12), 1267–1274. https://doi.org/10.1176/appi.ajp.2012.11071114
Resler, G., Lavie, R., Campos, J., Mata, S., Urbina, M., García, A., Apitz, R., & Lima, L. (2008). Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes. Neuroimmunomodulation, 15(3), 145–152. https://doi.org/10.1159/000151527
Saraswathy, K. N., Ansari, S. N., Kaur, G., Joshi, P. C., & Chandel, S. (2019). Association of vitamin B12 mediated hyperhomocysteinemia with depression and anxiety disorder: A cross-sectional study among Bhil indigenous population of India. Clinical Nutrition ESPEN, 30, 199–203. https://doi.org/10.1016/j.clnesp.2019.01.009
Syed, E. U., Wasay, M., & Awan, S. (2013). Vitamin B12 supplementation in treating major depressive disorder: A randomized controlled trial. The Open Neurology Journal, 7, 44–48. https://doi.org/10.2174/1874205X01307010044
Tu, J., Mo, X., Chen, Z., Xi, L., Wu, C., Xie, T., & Chen, Y. (2025). Association of different folate statuses with sleep disturbances in adults in the US: Data from NHANES 2007–2016. Sleep Health, 11(3), 326–334. https://doi.org/10.1016/j.sleh.2025.01.005
Venkatasubramanian, R., Kumar, C. N., & Pandey, R. S. (2013). A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes. Journal of Affective Disorders, 150(2), 644–648. https://doi.org/10.1016/j.jad.2013.02.029
Zhang, Y. X., Yang, L. P., Gai, C., Cheng, C. C., Guo, Z. Y., Sun, H. M., & Hu, D. (2022). Association between variants of MTHFR genes and psychiatric disorders: A meta-analysis. Frontiers in Psychiatry, 13, Article 976428. https://doi.org/10.3389/fpsyt.2022.976428
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aleksandra Suchołbiak, Oskar Mikołajczyk, Maja Podolak, Radosław Jan Walkowski, Irmina Grygutis, Urszula Jarzęcka, Kornelia Julia Fimiarz, Sonia Pawełkiewicz, Kinga Łysak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
